A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult (clinicaltrials.gov) - Jun 9, 2026 - P1 | N=68 | Recruiting | Sponsor: Benethera (Shaoxing) Biotechnology Co., Ltd.
New P1 trial • Crohn's disease • Gastroenterology • Gastrointestinal Disorder • Immunology • Inflammation • Inflammatory Bowel Disease • Ulcerative Colitis
|